A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Clinical trial NCT05489705 · RECRUITING
Trial details
- NCT number
- NCT05489705
- Sponsor
- Bristol-Myers Squibb
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-16
- Primary completion
- 2029-08-17
- Enrollment
- 1700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.